BindingDB logo
myBDB logout

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26735842 27 Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins.EBI Centre National de la Recherche Scientifique (CNRS)
26230603 176 Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors.EBI GlaxoSmithKline
26155854 125 Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors.EBI GlaxoSmithKline
26080064 141 Structure-Based Design of┐-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors.EBI University of Michigan
25971770 10 Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.EBI Pfizer Inc
25314628 12 Fragment-based screening of the bromodomain of ATAD2.EBI Vanderbilt University School of Medicine
25249180 146 The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.EBI GlaxoSmithKline
21568322 16 Discovery and characterization of small molecule inhibitors of the BET family bromodomains.EBI GlaxoSmithKline
30064119 8 In silico fragment-based drug design with SEED.EBI University of Z£rich
30226378 40 Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors.EBI GlaxoSmithKline
29657099 55 Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors.EBI Celgene Quanticel Research
29656650 151 Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain.EBI University of Strathclyde
29169673 115 Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300.EBI WuXi AppTec Co., Ltd.
28463487 185 Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor.EBI University of Michigan
30015487 96 Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor.EBI TBA
28068087 80 Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.EBI University College London
28714688 105 Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.EBI University College London